As per the agreement, Sanofi will manufacture 125 million doses of the Covid-19 vaccine in Europe. Initial supplies of vaccine are expected to come out of Sanofi’s facilities
The post Sanofi to manufacture 125 million doses of Pfizer-BioNTech’s Covid-19 vaccine appeared first on Pharmaceutical Business review.
This is not a CAPTIS article. Originally, it was published here.